Qingdi Quentin Li


Q. Quentin Li is a research scientist at the National Institutes of Health, and was an assistant professor at the Mary Babb Randolph Cancer Center, West Virginia University Robert C. Byrd Health Sciences Center. He was a guest (visiting) professor for six reputed universities in China. He obtained an M.D. from China and worked as dermatologist at Sun Yat-Sen University School of Medicine. He also received his M.S. in microbiology & immunology and Ph.D. in pharmacology & experimental therapeutics from the University of Maryland School of Medicine, with postdoctoral training in molecular and cell biology of cancer in Medical Oncology Branch (formerly Medicine Branch) of the Center for Cancer Research at the National Cancer Institute. He is a member of the American Association for Cancer Research. He served as principal investigator on several grants funded by the National Institutes of Health and a pharmaceutical company. He was elected to Who’s Who in Medicine & Healthcare, Who’s Who in Science & Engineering, Who’s Who in America, and Who’s Who in the World in 2002 and 2003.

Research Interests:

Cellular metabolism, Cancer epigenetics, Cancer chemotherapy & epigenetic therapy, Molecular and cell biology of cancer, Photoimmunotherapy, Oncopharmacology, New antitumor drug research & development, Natural products as novel anticancer agents, Apoptosis & cell cycle control in cancer cells, DNA repair and platinum drug resistance in carcinomas, Identification of biomarkers & epigenetic markers for diagnosis & treatment of carcinomas, Epigenetic regulation of gene expression in T cells & tumor cells.

Open Access Journals

Recently Released Issues

Social Network

Loading ....
Loading ....
Loading ....

Abstracting and Indexing

Boffin Access use Crossref Similarity Check for averting plagiarism


Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to

Send Information

Subscribe to our Newsletter

Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.


We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org